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A  68-year-old  man  was  referred  to  our  hospital  for the  evaluation  and  treatment  of chest  discomfort  and
syncope.  He  was  diagnosed  with  variant  angina  by prolonged  ischemic  episode  with  ST-segment  elevation
in leads  II, III, and  aVF. His  symptoms  had  a  seasonal  trend  and occurred  only  from  April  to  September.  In
other seasons,  he  had  no  symptoms  even  with  no  medication.  He had  a history  of nasal  polyps  and  allergic
rhinitis.  His  symptoms  increased  in  frequency  and  intensity,  and  the  attacks  were  not  fully  controlled
by  multiple  drug  therapy.  Sarpogrelate  hydrochloride,  however,  resulted  in  complete  resolution  of  his
symptoms.  Further  examination  revealed  that  he was  allergic  to mites,  Dermatophagoides  farina,  which
were prevalent  mainly  from  April  to  September.  The  allergic  mechanism  was  suggested  to be involved
in the  seasonal  variety  in angina  attacks.
<Learning  objective:  We  present  a 68-year-old  male  with  variant  angina.  Seasonal  variation  in his
frequency  of  the  attacks  suggested  the involvement  of allergic  reactions.  While  medications  includ-
ing  calcium  channel  blockers  and  nitrates  failed  to suppress  the  angina  attack,  adding  sarpogrelate,
a  selective  5-HT2A  antagonist,  signiﬁcantly  prevented  symptoms  of  recurrent  coronary  vasospasm.
Allergic  mechanism  was  suggested  to be  involved  in the pathogenesis  of  coronary  vasospasm  in  this
2  Jap
case.>
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Variant angina, ﬁrst described by Prinzmetal in 1959, is a syn-
rome of chest pain caused by myocardial ischemia secondary to
eversible coronary artery vasospasm that typically occurs at rest
nd is associated with transient ST segment elevation. There is a
ircadian variation with an increased prevalence of angina attacks
rom midnight to early morning. However, there have been no
eports about seasonal variation in variant angina. Here, we  report
 case of refractory variant angina whose attacks have seasonal fea-
ures. The attacks were controlled by sarpogrelate hydrochloride,
n antagonist of the 5-hydroxytryptamine subtype 2A (5-HT2A)
eceptor [1].
ase reportA 68-year-old man  had chest discomfort which lasted 10 min
n June 2008. He was admitted to hospital (his ﬁrst admission)
nd underwent coronary angiography (CAG). CAG showed no ﬁxed
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stenosis and he was  prescribed with diltiazem until his symptoms
disappeared in August 2008.
In June 2009, he had chest discomfort again. He also reported
recurrent episodes of syncope at the time of chest discomfort.
He was referred to our hospital for the evaluation and treatment
of chest discomfort and syncope in September 2009 (his second
admission). The episodes of his symptoms mostly occurred early in
the morning, lasted on average 10 min  and responded well to sub-
lingual nitrates. His symptoms had a seasonal trend and occurred
only from April to September (Fig. 1). In other seasons, he had
no symptoms even with no medication. He had a history of nasal
polyps and allergic rhinitis. He smoked half a pack of cigarettes
per day for 20 years and stopped smoking 30 years previously. His
family history was unremarkable. Physical examination, 12-lead
electrocardiogram (ECG), and chest X-ray were unremarkable, and
rapid assay of troponin T were negative. Head-up tilt test was also
normal. An exercise treadmill test showed negative for myocardial
ischemia. From these results, we  performed CAG with suspicion
of variant angina. It revealed normal coronary artery and provoca-
tion of coronary vasospasm with acetylcholine maximum dose of
100 g was negative. He was discharged from our hospital without
medication because he had no symptoms.
The patient, however, continued to have chest discomfort and
syncope of increasing frequency and intensity in May  2010. Because
vier Ltd. All rights reserved.
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hese symptoms were accompanied by bradycardia and Holter ECG
ould not detect any ECG changes, a loop recorder was  implanted to
eveal the cause of his syncope in June 2010 (his third admission).
t showed bradycardia (27 bpm) approximately 5 min  following his
ymptoms of chest discomfort (Fig. 2).
He exhibited a prolonged ischemic episode with ST-segment
levation in leads II, III, and aVF (Fig. 2) and his symptoms were
elieved by taking sublingual nitrate, which led to the diagnosis of
ariant angina in July 2010 (his fourth admission). He took diltia-
em and nicorandil until October 2010.
He was admitted to our hospital because his attacks were so
requent in May  2011 (his ﬁfth admission). His symptoms were not
Fig. 2. (a) Symptom-triggered and automatic record of loop recorder. atient’s angina attacks.
controlled by multiple drug therapy (isosorbide dinitrate 40 mg,
nifedipine 40 mg, ﬂuvastatin sodium 20 mg,  benidipine 4 mg,  dil-
tiazem 200 mg,  nicorandil 15 mg,  and intravenous nitroglycerin
0.7 g/kg/min). On the 7th hospital day, sarpogrelate hydrochloride
100 mg  t.i.d was added, which resulted in substantial resolution
of his symptoms (Fig. 3). He was discharged from our hospital in
June 2011 with the same medications (isosorbide dinitrate 40 mg,
nifedipine 40 mg,  ﬂuvastatin sodium 20 mg,  benidipine 4 mg,  diltia-
zem 200 mg,  nicorandil 15 mg,  sarpogrelate hydrochloride 300 mg).
After discharge, he felt minimal chest discomfort from June to
September 2011. He was  prescribed diltiazem 200 mg  and nico-
randil 15 mg since September 2011. In April 2012, we added
(b) Electrocardiogram at the time of anginal attack in the ward.
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oFig. 3. Clinical course and the patient’s symptoms.
sosorbide dinitrate 40 mg,  nifedipine 40 mg,  ﬂuvastatin sodium
0 mg,  and sarpogrelate hydrochloride 300 mg.  Finally, his symp-
oms completely disappeared in 2012.
We  performed further tests to investigate the cause of the sea-
onal variation in the attacks. An allergic screening test showed
e was allergic to Dermatophagoides farina,  mites that are mostly
istributed from April to September. Scratch test was  positive
nd speciﬁc IgE antibody test was also strongly positive (class
) to this antigen. This antigen also stimulated release of his-
amine in vitro by histamine releasing test. He had no eosinophilia
eosinophil counts: 0.10–0.47 × 109/L) or elevation of C-reactive
rotein (0.03–0.19 mg/dl), and there was no signiﬁcant change in
hese after treatment. His allergic symptoms did not change after
aking sarpogrelate hydrochloride.
iscussion
We  report a case of refractory variant angina whose attacks
ave seasonal features. An allergic mechanism was suggested to
e involved in his seasonal attacks. The symptoms were controlled
ith sarpogrelate hydrochloride.
Allergic diseases such as bronchial asthma and allergic rhinitis
how seasonal variation because antigens are distributed by sea-
on. This case had allergy to D. farina which are mostly distributed
rom April to September. Previous reports suggested a relationship
etween allergic reactions and coronary artery spasm [2].
Variant angina associated with eosinophilia was reported to be
ften multi-focal and resistant to high-dose vasodilators [3].  And
he risk of recurrence was high, but was reduced by treatment
ith prednisone [3]. We  did not use prednisone because he had no
osinophilia and his symptoms could be controlled without pred-
isone which has strong side effects.
Microscopic analysis of pathologic tissue from a patient with
oronary vasospasm revealed more mast cells in the adventitia
f an artery involved in a previous vasospasm, compared with
[ Cases 6 (2012) e176–e178
those found in arteries from patients with atherosclerotic coronary
artery disease, or sudden death without documented vasospasm
[4]. Mast cells have an important role in allergic reactions. These
cells increase in the adventitia of the damaged artery and pro-
duce 5-hydroxytryptamine (5-HT) and histamine. The relationship
between these mediators and variant angina has been reported
[2,5–7]. Transcardiac plasma levels of 5-HT in patients with vari-
ant angina were signiﬁcantly higher than those in control patients
with nonischemic heart disease [5]. Intracoronary infusion of 5-
HT caused angina attacks, ECG changes, and localized occlusive
epicardial coronary artery spasm for variant angina [6]. In addi-
tion, supersensitivity of isolated coronary artery to 5-HT was also
reported in a patient with variant angina [7].  Histamine can also
provoke coronary artery spasm in patients with variant angina [2].
He was treated with sarpogrelate, a selective 5-HT2A antago-
nist. It inhibits responses to 5-HT mediated by 5-HT2A receptors
such as platelet aggregation, vasoconstriction, and vascular smooth
muscle cell proliferation [1].  The 5-HT2A receptor was  suggested
to play a role in the pathogenesis of coronary spasm [8,9]. The
potential usefulness of sarpogrelate was  also reported clinically
[10]. Our patient presented with severe symptoms not controlled
by nitroglycerin intravenous infusion. While medications includ-
ing calcium channel blockers and nitrates failed to suppress the
angina attack, sarpogrelate signiﬁcantly prevented symptoms of
recurrent coronary vasospasm. The above observations suggest that
sarpogrelate possibly has an additive effect to conventional anti-
spasm medications.
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